Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
Boldt AB, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 19(3):296–306 (2002).
Casselbrant ML, Mandel EM. The genetics of otitis media. Curr Allergy Asthma Rep 1(4):353–357 (2001).
Casselbrant ML, Mandel EM. Genetic susceptibility to otitis media. Curr Opin Allergy Clin Immunol 5(1):1–4 (2005).
Daly KA, Brown WM, Segade F, Bowden DW, Keats BJ, Lindgren BR, Levine SC, Rich SS. Chronic and recurrent otitis media: a genome scan for susceptibility loci. Am J Hum Genet 75(6):988–997 (2004).
den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7–12 (2000).
Garred P, Brygge K, Sorensen CH, Madsen HO, Thiel S, Svejgaard A. Mannanbinding protein—levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin Exp Immunol 94(1):99–104 (1993).
Homoe P, Madsen HO, Sandvej K, Koch A, Garred P. Lack of association between mannose-binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand J Infect Dis 31(4):363–366 (1999).
Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40(1):37–44 (1994).
Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155(6):3013–3020, 1995.
Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 343(5):338–344 (2000).
Nuytinck L, Shapiro F. Mannose-binding lectin: laying the stepping stones from clinical research to personalized medicine. Personalized Med 1(1):35–52 (2004)
Rich SS, Daly K, Levine SC. Familial aggregation and risk factors for chronic recurrent otitis media. In: Recent advances in otitis media: proceedings of the sixth international symposium 1995 BCDecker (Hamilton), 65–68 (1996).
Straetemans M, Wiertsema SP, Sanders EA, Rijkers GT, Graamans K, Van Der Baan B, Zielhuis GA. Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and fc receptor polymorphisms for IgG. J Clin Immunol 25(1):78–86 (2005).
Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 39(12):2046–2051 (1996).
Tezcan I, Yilmaz Y, Oner F, Yel L, Sanal O, Ersoy F, Onerci M, Berkel AI. Defective serum opsonization activity in children aged 6–48 months having acute purulent otitis media. Turk J Pediatr 39(4):453–457 (1997).
Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43(1–2):86–96 (2006)
Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 40(7):423–429 (2003).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Nuytinck, L., De Meester, E., Van Thielen, M., Govaerts, P. (2006). Role of Mannose-Binding Lectin (MBL2) Genotyping in Predicting the Risk of Recurrent Otitis Media (rOM). In: Lambris, J.D. (eds) Current Topics in Complement. Advances in Experimental Medicine and Biology, vol 586. Springer, Boston, MA. https://doi.org/10.1007/0-387-34134-X_19
Download citation
DOI: https://doi.org/10.1007/0-387-34134-X_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32231-5
Online ISBN: 978-0-387-34134-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)